HETERO USA INC

Company Introduction:

HETERO USA INC is the United States subsidiary of Hetero Drugs Limited, a major pharmaceutical company headquartered in India. Hetero Drugs Limited is recognized as one of the largest privately held pharmaceutical companies in India, with significant operations in research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs) and finished dosage formulations for various therapeutic areas.

Classification:

The parent company, Hetero Drugs Limited, which is based in India, is fundamentally a manufacturer (factory). HETERO USA INC primarily operates as a trading, distribution, and marketing arm for the pharmaceutical products manufactured by its parent company. Therefore, the enterprise is classified as a manufacturer.

Hetero USA Inc., a subsidiary of the Indian pharmaceutical company Hetero Group, primarily manufactures and sells a wide range of pharmaceutical products. These generally include:

1. Active Pharmaceutical Ingredients (APIs): These are the raw materials used in the production of finished drug products.

2. Finished Dosage Forms (FDFs): These are the completed pharmaceutical products ready for patient use.

3. Generic Pharmaceuticals: Hetero USA Inc. focuses on generic versions of various medicines.

The products span multiple therapeutic areas, such as:

Antiretrovirals for HIV/AIDS treatment.

Antivirals for conditions like Hepatitis.

Anticancer drugs (Oncology).

Cardiovascular medications.

Neurological disorder treatments.

Antidiabetic drugs.

Anti-infectives, including antibiotics and antifungals.

Anti-inflammatory and pain management drugs.

Dermatological preparations.